NCT04439474View on ClinicalTrials.gov

Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes

NACompletedINTERVENTIONAL

Enrollment

187

Participants

Timeline

Start Date

October 10, 2018

Primary Completion Date

November 10, 2019

Study Completion Date

February 10, 2020

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Vitamin D3

For up to 8 days, 50,000 units of vitamin D3 are given daily to patients in the first group so that the serum level of vitamin D reaches above 30 g / ml.

DRUG

Routine treatment

In this group, patients receive their usual medications and treatments

Trial Locations (1)

0

Mohammad Sadegh Bagheri Baghdasht, Tehran

All Listed Sponsors

lead

Baqiyatallah Medical Sciences University

OTHER

NCT04439474 - Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter